The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2026

Filed:

Feb. 18, 2020
Applicant:

Hangzhou Dac Biotech Co., Ltd, Hangzhou, CN;

Inventors:

Robert Zhao, Lexington, MA (US);

Qingliang Yang, Hangzhou, CN;

Yuanyuan Huang, Hangzhou, CN;

Shun Gai, Hangzhou, CN;

Hangbo Ye, Hangzhou, CN;

Linyao Zhao, Hangzhou, CN;

Huihui Guo, Hangzhou, CN;

Lu Bai, Hangzhou, CN;

Wenjun Li, Hangzhou, CN;

Junxiang Jia, Hangzhou, CN;

Zhixiang Guo, Hangzhou, CN;

Jun Zheng, Hangzhou, CN;

Xiaoxiao Chen, Hangzhou, CN;

Xiangfei Kong, Hangzhou, CN;

Chen Lin, Hangzhou, CN;

Yong Du, Hangzhou, CN;

Yu Zhang, Hangzhou, CN;

Lei Zhou, Hangzhou, CN;

Xiuzhen Zhang, Hangzhou, CN;

Xiuhong Zheng, Hangzhou, CN;

Binbin Chen, Hangzhou, CN;

Yanlei Yang, Hangzhou, CN;

Meng Dai, Hangzhou, CN;

Yifang Xu, Hangzhou, CN;

Zhongliang Fan, Hangzhou, CN;

Xiaomai Zhou, Hangzhou, CN;

Xingyan Jiang, Hangzhou, CN;

Miaomiao Chen, Hangzhou, CN;

Lingli Zhang, Hangzhou, CN;

Yanhua Li, Hangzhou, CN;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/08 (2019.01); A61K 9/19 (2006.01); A61K 47/54 (2017.01); A61K 47/55 (2017.01); A61K 47/64 (2017.01); A61K 47/65 (2017.01); A61K 51/08 (2006.01);
U.S. Cl.
CPC ...
A61K 38/08 (2013.01); A61K 9/19 (2013.01); A61K 47/545 (2017.08); A61K 47/548 (2017.08); A61K 47/55 (2017.08); A61K 47/64 (2017.08); A61K 47/65 (2017.08); A61K 51/088 (2013.01);
Abstract

A formulation of conjugates of tubulysin analogs with a cell-binding molecule having a structure represented by Formula (I), wherein T, L, m, n, ----, R, R, R, R, R, R, R, R, R, R, R, R, and Rare as defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.


Find Patent Forward Citations

Loading…